Metabolism - Clinical and Experimental
Volume 44, Issue 8 , Pages 1033-1037 , August 1995

Is obesity-related insulin status the cause of blunted growth hormone secretion in turner's syndrome?

  • Fabrizio Vaccaro

      Affiliations

    • Department of Pediatrics, “Tor Vergata” University, Rome, Italy
    • Department of Pediatrics, “La Sapienza” University, Rome, Italy
    • ,
  • Stefano Cianfarani

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Stefano Cianfarani, MD, Department of Pediatrics, Dip.San.Pubbl.Biol.Cell., “Tor Vergata” University, via di Tor Vergata, 135, 00133-Rome, Italy.
    • Department of Pediatrics, “Tor Vergata” University, Rome, Italy
    • Department of Pediatrics, “La Sapienza” University, Rome, Italy
    • ,
  • Anna Maria Pasquino

      Affiliations

    • Department of Pediatrics, “Tor Vergata” University, Rome, Italy
    • Department of Pediatrics, “La Sapienza” University, Rome, Italy
    • ,
  • Brunetto Boscherini

      Affiliations

    • Department of Pediatrics, “Tor Vergata” University, Rome, Italy
    • Department of Pediatrics, “La Sapienza” University, Rome, Italy

Received 18 July 1994 ,Accepted 29 November 1994.

References 

  1. Brook CGD. Growth hormone deficiency in Turner's syndrome. N Engl J Med. 1978;298:1203–1204
  2. Laczi F, Julesz J, Janaki T, et al.  Growth hormone reserve capacity in Turner's syndrome. Horm Metab Res. 1979;11:664–666
  3. Ranke MB, Blum WF, Haug F, et al.  Growth hormone, somatomedin levels and growth regulation in Turner's syndrome. Acta Endocrinol (Copenh). 1987;116:305–313
  4. Pasquino AM, Bernardini S, Cianfarani S, et al.  GH assessment and three years' hGH therapy in girls with Turner syndrome. Horm Res. 1992;38:120–124
  5. Ross JL, Long LM, Loriaux DJ, et al.  Growth hormone secretory dynamics in Turner syndrome. J Pediatr. 1985;106:202–206
  6. Lin TH, Kirkland JL, Kirkland RT. Growth hormone assessment and short term treatment with growth hormone in Turner's syndrome. J Pediatr. 1988;112:919–922
  7. Lanes R, Brito S, Suniaga M, et al.  Growth hormone secretion in pubertal age patients with Turner's syndrome. J Clin Endocrinol Metab. 1990;71:770–772
  8. Zadik Z, Landau H, Chen M, et al.  Assessment of growth hormone (GH) axis in Turner's syndrome using 24-hour integrated concentrations of GH, insulin-like growth factor-I, plasma GHbinding activity, GH binding to IM9 cells, and GH response to pharmacological stimulation. J Clin Endocrinol Metab. 1992;75:412–416
  9. Cianfarani S, Vaccaro F, Pasquino AM, et al.  Reduced growth hormone secretion in Turner syndrome: Is body weight a key factor?. Horm Res. 1994;41:27–32
  10. Lu PW, Cowell CT, Jmenez M, et al.  Effect of obesity on endogenous secretion of growth hormone in Turner's syndrome. Arch Dis Child. 1991;66:1184–1190
  11. Ranke MB, Pfluger H, Rosendhal W, et al.  Turner syndrome: Spontaneous growth in 150 cases and review of the literature. Eur J Pediatr. 1983;141:81–88
  12. Kopelman PG. Neuroendocrine function in obesity. Clin Endocrinol (Oxf). 1988;28:675–689
  13. Rogol AD. Growth and growth hormone secretion at puberty: The role of gonadal steroid hormones. Acta Paediatr Scand. 1992;81:15–20 [Suppl]
  14. Cameron N. The Measurements of Human Growth. Sydney, Australia: Croom Helm; 1984;
  15. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child. 1976;51:170–179
  16. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of Hand and Wrist. Stanford, CA: Stanford University Press; 1959;
  17. Passmore R, Eastwood MA. Human Nutrition and Dietitics. ed 8. Edinburgh, UK: Churchill Livingstone; 1986;
  18. Spadoni GL, Cianfarani S, Bernardini S, et al.  Twelve-hour spontaneous nocturnal growth hormone secretion in growth retarded patients. Clin Pediatr. 1988;27:473–478
  19. Caro JF. Insulin resistance in obese and nonobese man. J Clin Endocrinol Metab. 1991;73:691–695
  20. Rosenfeld RG, Frane J, Attie KM, et al.  Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome. J Pediatr. 1992;121:49–55
  21. Cianfarani S, Vaccaro F, Boscherini B. What is the rationale of growth hormone therapyin Turner's syndrome?. Lancet. 1994;344:114–115
  22. Tanaka K, Inoue S, Numata K, et al.  Very-low-calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and l-DOPA in obesity. Metabolism. 1990;39:892–896
  23. Kelijman M, Frohman LA. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects. J Clin Endocrinol Metab. 1988;66:489–494
  24. Abdenur JE, Vaquero Solans C, Smith MM, et al.  Body composition and spontaneous growth hormone secretion in normal short stature children. J Clin Endocrinol Metab. 1994;78:277–282
  25. Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific and negative determinants of the frequency and amplitude of GH secretory burst and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab. 1991;73:1081–1088
  26. Veldhuis JD, Sotos JF, Sherman BM, et al.  Decreased metabolic clearance of endogenous GH and specific alterations in the pulsatile mode of GH secretion occur in prepubertal girls with Turner's syndrome. J Clin Endocrinol Metab. 1991;73:1073–1080
  27. Weaver JU, Noonan K, Kopelman PG. An association between hypothalamic-pituitary dysfunction and peripheral endocrine function in extreme obesity. Clin Endocrinol (Oxf). 1991;35:97–102
  28. Melmed S. Insulin suppresses growth hormone secretion by rat pituitary cells. J Clin Invest. 1984;73:1425q433
  29. Isaacs RE, Gardner DG, Baxter JD. Insulin regulation of rat growth hormone gene expression. Endocrinology. 1987;120:2022–2028
  30. Massa G, Bouillon R, Vanderschueren-Lodeweyckx M. Serum growth hormone (GH)-binding protein and insulin-like growth factor-I levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol. J Clin Endocrinol Metab. 1992;75:1298–1302
  31. Hochberg Z, Hertz P, Colin V, et al.  The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I) and IGF-I receptors in obesity and anorexia nervosa. Metabolism. 1992;41:106–112
  32. Leung DW, Spencer SA, Cachianes G, et al.  Growth hormone receptor and serum binding protein: Purification, cloning and expression. Nature. 1987;330:537–543
  33. Massa G, de Zegher F, Vanderschueren-Lodeweyckx M. Serum growth hormone-binding proteins in the human fetus and infant. Pediatr Res. 1992;32:69–72
  34. Baxter RC, Bryson JM, Turtle JR. Somatogenic receptors of rat liver: Regulation by insulin. Endocrinology. 1980;107:1176–1181
  35. Postel-Vinay MC, Durand D, Lopez S, et al.  Increased growth hormone binding to liver membranes of obese Zucker rats. Horm Metab Res. 1990;22:741
  36. Massa G, Dooms L, Bouillon R, et al.  Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1993;36:239–243
  37. Cianfarani S, Holly JMP. Somatomedin-binding proteins: What role do they play in the growth process?. Eur J Pediatr. 1989;149:76–79
  38. Holly JMP, Biddlecombe RA, Dunger DB, et al.  Circadian variation of GH independent IGF-binding protein in diabetes mellitus and its relationship to insulin. Clin Endocrinol (Oxf). 1988;29:667–675
  39. Pao C-I, Farmer PK, Begovic S, et al.  Expression of hepatic insulin-like growth factor-I and insulin-like growth factor-binding protein-1 genes is transcriptionally regulated in streptozotocin-diabetic rats. Mol Endocrinol. 1992;6:969–977
  40. Weaver JU, Holly JMP, Kopelman PG, et al.  Decreased sex hormone binding globulin (SHBG) and insulin-like growth factor binding protein (IGFBP-1) in extreme obesity. Clin Endocrinol (Oxf). 1990;33:415–422
  41. Conover CA, Lee PDK, Kanaley JA, et al.  Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. J Clin Endocrinol Metab. 1992;74:1355–1360
  42. Taylor AM, Dunger DB, Preece MA, et al.  The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin-dependent diabetics. Clin Endocrinol (Oxf). 1990;32:229–239
  43. Cianfarani S, Holly JMP, Pasquino AM, et al.  Insulin-like growth factor binding protein 1 (IGFBP-1) levels in Turner syndrome. Horm Metab Res. 1992;24:537–540
  44. Rappaport R, Sauvion S. Possible mechanism for the growth retardation in Turner's syndrome. Acta Paediatr. 1989;359:82–86

PII: 0026-0495(95)90101-9

Metabolism - Clinical and Experimental
Volume 44, Issue 8 , Pages 1033-1037 , August 1995

Article Tools